Sequential Backbone Assignment of Peroxisome Proliferator-Activated Receptor-γ Ligand Binding Domain

Hubert Riepl, Till Maurer(Boehringer Ingelheim (Germany)), Hans Robert Kalbitzer, Rainer Hartl(University of Regensburg), Stefan G. Kauschke(Boehringer Ingelheim (Germany)), Herbert Nar(Boehringer Ingelheim (Germany)), Margit Bauer(Boehringer Ingelheim (Germany))
Journal of Biomolecular NMR
July 1, 2005
10.1007/s10858-005-7556-1
Cited by 4

Related Papers

A specific antidote for dabigatran: functional and structural characterization
|Blood|2013|562
Crystal structure analysis of oxidized Pseudomonas aeruginosa azurin at pH 5·5 and pH 9·0
|Journal of Molecular Biology|1991|487
Structure-Based Design of Novel Potent Nonpeptide Thrombin Inhibitors
|Journal of Medicinal Chemistry|2002|454
Biophysics in drug discovery: impact, challenges and opportunities
|Nature Reviews Drug Discovery|2016|383
8-(3-(<i>R</i>)-Aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a Highly Potent, Selective, Long-Acting, and Orally Bioavailable DPP-4 Inhibitor for the Treatment of Type 2 Diabetes
|Journal of Medicinal Chemistry|2007|285